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Abstract 
Background: To determine the frequency of 
hypothyroidism in adult obese patients. 
Methods:  In this cross sectional study 116 obese 
patients who reported in the outpatient department 
were included. Patients having body mass index 
(BMI) of more than 30 were considered obese. 
Patients suffering from chronic diseases such as 
tuberculosis, hypertension, ischemic heart disease, 
other endocrine disorders  and patients under 18 
years of age were not included. Registration at 
patient selection was followed by drawing of 4 - 5 ml 
of blood sample in the morning in plain serum 
bottle. The drawn samples were sent for serum TSH 
and serum free T4 levels . Patients having serum 
TSH level of more than 4.5 mIU/L and T4 levels of 
less than 8.0 pmol/L were considered hypothyroid. 
The patient’s height and weight were also measured 
using same machine for every patient for calculating 
BMI. The mean with standard deviation was 
calculated for age (years). Frequencies were 
calculated for hypothyroidism in obese patients and 
Chi Square test was applied to calculate the p value.  
Results: Out of 116 patients 6 (5.2%) of the obese 
cases were hypothyroid. The frequency of 
hypothyroid in our obese population is insignificant.  
Conclusion: There is no significant correlation 
between hypothyroid and obesity in our population.  
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Introduction 
Over weight population is a major health issue in the 
world. Hypothyroidism appears to be associated with 
obesity but little data is available as regards the 
association between variations in thyroid function tests 
seen in general population and in people with 
increased body weight.1 Both hypothyroidism and 
obesity are independent cardiovascular risk factors as 
well.2 Thyroid hormones have been suggested in the 
treatment of obesity. Various studies on obese women 
have shown a relationship between decreased thyroid 
functions and increased body weight.3 
Hypothyroidism appears to improve in majority of 
morbidly obese patients who underwent laparoscopic 
Roux-en-Y (LRYGB) surgery.4 The diagnosis of 
hypothyroidism in obese patients is thus sometimes 
missed because it is not always associated with 
symptoms or signs attributed to it or because the 
clinical features manifest so slowly that clinicians may 
fail to notice them.5  
One study carried out in Hyderabad India showed 
overt hypothyroidism was present in 33% of the obese 
population which is a significant number.6 No such 
study has been carried out in our population to 
determine the association between hypothyroidism 
and obesity.  
  
Patients and Methods  
The study was carried out in the Department of 
Medicine, Military Hospital Rawalpindi. All the obese 
patients who reported in the outpatient department 
from 2nd March, 2009 to 2nd Sep 2009 were included in 
the study. Patients having body mass index (BMI) of 
more than 30 were considered obese. Patients suffering 
from chronic diseases such as tuberculosis, 
hypertension and ischemic heart disease, or other 
endocrine disorders and patients under 18 years of age 
were not included. Registration at patient selection 
was followed by drawing of 4 - 5 ml of blood sample 
in the morning in plain serum bottle. The drawn 
samples were labelled and sent for serum TSH and 
serum free T4 levels . The samples were analyzed on 
fully automated hormone analyzer. The reference 
range for normal serum TSH level was 0.4 to 4.5 
mIU/L and for serum T4 it was 8.0 to 21pmol/L. 
Patients having serum TSH level of more than 4.5 
mIU/L and T4 levels of less than 8.0 pmol/L were 
considered hypothyroid. The patient’s height and 
weight were also measured using same machine for 
every patient for calculating BMI. The mean with 
standard deviation was calculated for age (years). 
Frequencies were calculated for hypothyroidism in 
obese patients and Chi Square test was applied to 
calculate the p value.  
 
Results 
Mean age of the patients (n=116) was 39 (± 15 years) 
with range of 18 to 75 years. Ninety one (78.4%) were 
males and 25 (21.6%) were females. Out of 116 
patients, 6 (5.2%) of the obese cases were hypothyroid 
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and the frequency of hypothyroidism in males was 4 
(4.39%) and in females was 2 (8%) (Table 1). Mean 
value of TSH in hypothyroid patients was14.6 (± 2.34) 
mIU/L , while in euthyroid patients it was 2.5 (± 0.23) 
mIU/L (Table 2).  Chi Square test was applied and p 
value was more than 0.05 which implies that 
frequency of hypothyroid patients in obese individuals 
is insignificant.  
 
Table 1. Gender wise thyroid status of the 
patients 
 Thyroid status of the 
Patient(Frequencies) % of Hypothyroid 
patients 
Normal Hypothyroid 
Patient’s 
gender 
Male 87 4 4.39% 
Female 23 2 8% 
Total 110 6 5.2% 
 
Table 2. Mean values of TSH and T4 in 
euthyroid and hypothyroid patients. 
Mean 
Value 
Hypothyroid 
Patients 
Euthyroid Subjects 
TSH  14.6 (± 2.34)mIU/L 2.5 (± 0.23) mIU/L 
T4  5.6 (± 0.44)pmol/L 16.4 (± 3.2) pmol/L 
p-value= >0.05 * 
*insignificant  
 
Discussion 
 Implicating abnormal thyroid function continues to be 
debated and identifying thyroid disease clinically can 
be challenging. Symptoms often develop so insidiously 
that they go unnoticed.7 When symptoms are reported, 
they are frequently confused with other health 
problems. 7,8  The picture of a typical hypothyroid 
patient vividly painted in medical textbooks is seldom 
seen in clinical practice. What we often see is a 
presentation that is not always identified by the 
history and the physical examination. The diagnosis of 
hypothyroidism is sometimes missed because it is not 
always associated with the symptoms or signs 
attributed to it or because the clinical features manifest 
so slowly that clinicians may fail to notice them.9,10 
Symptoms also lack specificity and clinicians often 
attribute them to common non-thyroid diseases. 
Conversely, several individuals with non-specific 
symptoms are diagnosed to have hypothyroidism 
when evaluated with the help of thyroid function 
tests.9 The U.S. Preventive Services Task Force 
recommends that clinicians remain alert to the subtle 
or non-specific nature of thyroid dysfunction and 
maintain a low threshold for the diagnostic evaluation 
of thyroid dysfunction.11 In one of the local studies 
carried out it was found that the presentation of 
hypothyroidism is non-specific and high degree of 
suspicion is required for its early diagnosis in our 
population. Lethargy was the commonest symptom 
and facial edema was the most prevalent sign in our 
population.5 
Variations in thyroid function are seen between 
individuals.12 Such differences in individual thyroid 
function are caused by a combination of genetic and 
environmental factors.13 Considerable differences may 
be seen in thyroid function between populations when 
estimated by median serum TSH levels. The optimal 
level for thyroid hormones and TSH in serum to attain 
physical and mental well being has not been 
established, but the trend these years is to narrow the 
range of serum TSH, regarded as optimal. Detrimental 
effects on the cardiovascular system have been 
reported for suppressed and particularly elevated 
serum levels of TSH. Even small differences in thyroid 
function with TSH variation within the normal 
laboratory range for patients on T4 substitution 
therapy are associated with measurable differences in 
resting energy expenditure (REE), but the impact on 
body mass index (BMI) remains unsettled.14 A 
prolonged decrease in REE might well lead to 
increased body weight in the current environment of 
food plenty and physical inactivity in many 
industrialized countries. Association between thyroid 
hormone levels, as seen in the general population, and 
body weight or BMI has only been described in few 
previous studies. A Puerto Rican study included 575 
obese patients and concluded that  8.2 % of their 
patients were either hypothyroid or had sub clinical 
hypothyroidism. The DanThyr Study showed a 
positive correlation between BMI and serum TSH, a 
negative correlation between BMI and serum free T4, 
and no association between BMI and serum free T3.  
Overweight is a major threat to public health, with the 
prevalence of obesity now exceeding 30% in the 
United States.15 Lifestyle is undoubtedly of major 
importance for weight gain in the population, but the 
interaction with other factors is far from elucidated in 
detail.16 In euthyroidism, subjects with a TSH in the 
upper normal range (2·5–4·5 mU/l) were more obese, 
had higher triglycerides, and had an increased 
likeliness for the metabolic syndrome. however it is 
suggested that in these subjects TSH should be 
followed on a regular bais.17 
 
Conclusion 
Incompatibility of studies performed to date has 
generated much confusion. The existence of the 
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components increases one’s cardiovascular disease 
risk. There is growing awareness among health care 
professionals to identify and initiate therapy for 
‘nontraditional’ cardiovascular disease risk factors, 
without negating the importance of identifying and 
treating the other traditional risk factors (e.g. smoking, 
age, sex and family history).Both hypothyroid and 
obesity still plays an important role in CVD . 
Therefore, if the identification of a ‘syndrome’ helps 
clinicians to recognize high-risk individuals, then the 
definition has served its clinical utility.  
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